Correlation Between Eliem Therapeutics and Denali Therapeutics
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Denali Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Denali Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Denali Therapeutics, you can compare the effects of market volatilities on Eliem Therapeutics and Denali Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Denali Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Denali Therapeutics.
Diversification Opportunities for Eliem Therapeutics and Denali Therapeutics
0.36 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Eliem and Denali is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Denali Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Denali Therapeutics and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Denali Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Denali Therapeutics has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Denali Therapeutics go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and Denali Therapeutics
Given the investment horizon of 90 days Eliem Therapeutics is expected to under-perform the Denali Therapeutics. In addition to that, Eliem Therapeutics is 1.33 times more volatile than Denali Therapeutics. It trades about -0.21 of its total potential returns per unit of risk. Denali Therapeutics is currently generating about -0.08 per unit of volatility. If you would invest 2,705 in Denali Therapeutics on September 2, 2024 and sell it today you would lose (205.00) from holding Denali Therapeutics or give up 7.58% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 90.48% |
| Values | Daily Returns |
Eliem Therapeutics vs. Denali Therapeutics
Performance |
| Timeline |
| Eliem Therapeutics |
| Denali Therapeutics |
Eliem Therapeutics and Denali Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and Denali Therapeutics
The main advantage of trading using opposite Eliem Therapeutics and Denali Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Denali Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Denali Therapeutics will offset losses from the drop in Denali Therapeutics' long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
| Denali Therapeutics vs. Tff Pharmaceuticals | Denali Therapeutics vs. Eliem Therapeutics | Denali Therapeutics vs. Inhibrx | Denali Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |